Interstitial Lung Disease Caused by Apalutamide for Metastatic Castration-Sensitive Prostate Cancer

被引：0
|
作者：
del Castillo-Acuna, Rocio [1 ]
Serradilla, Ana [2 ,3 ]
Lopez-Campos, Fernando [4 ]
Counago, Felipe [5 ,6 ]
机构：
[1] Hosp Univ Punta Europa, Dept Radiat Oncol, Algeciras, Spain
[2] Complejo Hosp Jaen, Dept Radiat Oncol, Jaen, Spain
[3] Hosp Univ Ramon & Cajal, Dept Radiat Oncol, Madrid, Spain
[4] Hosp San Francisco Asis, Dept Radiat Oncol GenesisCare, Madrid, Spain
[5] Hosp Vithas La Milagrosa, Dept Radiat Oncol GenesisCare, Madrid, Spain
[6] GenesisCare Espana, Nacl Clin & Invest, Madrid, Spain
来源：
ARCHIVOS DE BRONCONEUMOLOGIA | 2024年 / 60卷 / 08期
关键词：
D O I：
10.1016/j.arbres.2024.04.009
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：537 / 538
页数：2
相关论文
共 50 条
  • [41] Attainment of early, deep prostate-specific antigen response in metastatic castration-sensitive prostate cancer: A comparison of patients initiated on apalutamide or enzalutamide
    Lowentritt, Benjamin
    Pilon, Dominic
    Khilfeh, Ibrahim
    Rossi, Carmine
    Muser, Erik
    Kinkead, Frederic
    Waters, Dexter
    Ellis, Lorie
    Lefebvre, Patrick
    Brown, Gordon
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2023, 41 (05) : 253.e1 - 253.e9
  • [42] Prostate Cancer: Developing Novel Approaches to Castration-Sensitive Disease
    Francini, Edoardo
    Taplin, Mary-Ellen
    CANCER, 2017, 123 (01) : 29 - 42
  • [43] Apalutamide-Induced Toxic Epidermal Necrolysis in a Caucasian Patient with Metastatic Castration-Sensitive Prostate Cancer: A Case Report and Review of the Literature
    Flynn, Calvin R.
    Liu, Shun-Chieh
    Byrne, Berbie
    Ralph, James
    Paz, Gabriela
    Anwar, Salman
    Buchalter, Jemma
    Fitzpatrick, Orla M.
    Markham, Trevor
    Donnellan, Paul
    CASE REPORTS IN ONCOLOGY, 2023, 16 (01): : 652 - 661
  • [44] Dose Per Body Weight Predicts Incidence and Severity of Apalutamide-Related Skin Rash in Metastatic Castration-Sensitive Prostate Cancer
    Suzuki, Kotaro
    Shiraishi, Yusuke
    Okamura, Yasuyoshi
    Bando, Yukari
    Hara, Takuto
    Okada, Keisuke
    Terakawa, Tomoaki
    Hyodo, Yoji
    Chiba, Koji
    Teishima, Jun
    Nakano, Yuzo
    Miyake, Hideaki
    CLINICAL GENITOURINARY CANCER, 2025, 23 (01)
  • [45] Attainment of early, deep prostate-specific antigen response in metastatic castration-sensitive prostate cancer: A comparison of patients initiated on apalutamide or enzalutamide.
    Lowentritt, Benjamin
    Pilon, Dominic
    Khilfeh, Ibrahim
    Rossi, Carmine
    Muser, Erik
    Kinkead, Frederic
    Waters, Dexter
    Ellis, Lorie
    Lefebvre, Patrick
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [46] Prostate-specific antigen kinetics in Asian patients with metastatic castration-sensitive prostate cancer treated with apalutamide in the TITAN trial: A post hoc analysis
    Ye, Ding-Wei
    Uemura, Hirotsugu
    Chung, Byung Ha
    Suzuki, Hiroyoshi
    Mundle, Suneel
    Bhaumik, Amitabha
    Singh, Anildeep
    Chowdhury, Simon
    Agarwal, Neeraj
    Chi, Kim N.
    Huang, Jian
    INTERNATIONAL JOURNAL OF UROLOGY, 2025, 32 (02) : 164 - 172
  • [47] Letter to the Editor: How We Treat Metastatic Castration-Sensitive Prostate Cancer
    Daungsupawong, Hinpetch
    Wiwanitkit, Viroj
    CANCER CONTROL, 2024, 31
  • [48] Apalutamide plus Androgen Deprivation Therapy for Metastatic Castration-Sensitive Prostate Cancer: Analysis of Pain and Fatigue in the Phase 3 TITAN Study
    Preisser, Felix
    Mandel, Philipp
    JOURNAL OF UROLOGY, 2021, 206 (04): : 923 - 923
  • [49] Treatment Intensification Patterns and Utilization in Patients with Metastatic Castration-Sensitive Prostate Cancer
    Heath, Elisabeth, I
    Dyson, Gregory E.
    Cackowski, Frank C.
    Hafron, Jason
    Powell, Isaac
    CLINICAL GENITOURINARY CANCER, 2022, 20 (06) : 524 - 532
  • [50] CAN LOCAL RADIOTHERAPY CONVERT METASTATIC CASTRATION-RESISTANT PROSTATE CANCER TO A CASTRATION-SENSITIVE DISEASE? A CASE REPORT
    Terrevazzi, Sara
    Niespolo, Rita Marina
    Colciago, Riccardo Ray
    Villa, Stefano Lorenzo
    Pacifico, Pietro
    Arcangeli, Stefano
    ANTICANCER RESEARCH, 2020, 40 (08) : 4592 - 4592
12345